Document is current
Any future updates will be listed below
-
Authors
Foudrat, Elise
Caillard, Sophie https://orcid.org/0000-0002-0525-4291
- License Information
-
More Information
Article History
Received: 18 December 2023
Accepted: 12 February 2024
First Online: 8 March 2024
Declarations
:
: Sophie Caillard received fees from AstraZeneca, France, for board expertise and congress travel. Elise Foudrat has no conflicts of interest to declare.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Informed consent to publication of identifying information has been received from both the patient and physician.
